87 FR 67 pg. 20389 - Foreign-Trade Zone (FTZ) 27—Boston, Massachusetts, Authorization of Production Activity, Wyeth Pharmaceuticals, LLC (mRNA Bulk Drug Substance), Andover, Massachusetts
Type: NOTICEVolume: 87Number: 67Page: 20389
Page: 20389Docket number: [B-80-2021]
FR document: [FR Doc. 2022-07367 Filed 4-6-22; 8:45 am]
Agency: Commerce Department
Sub Agency: Foreign-Trade Zones Board
Official PDF Version: PDF Version
[top]
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-80-2021]
Foreign-Trade Zone (FTZ) 27-Boston, Massachusetts, Authorization of Production Activity, Wyeth Pharmaceuticals, LLC (mRNA Bulk Drug Substance), Andover, Massachusetts
On December 3, 2021, Wyeth Pharmaceuticals, LLC submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 27R, in Andover, Massachusetts.
The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (86 FR 70439, December 10, 2021). On April 4, 2022, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including section 400.14.
Dated: April 4, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-07367 Filed 4-6-22; 8:45 am]
BILLING CODE 3510-DS-P